THERACLION
6announcements published
since October 2026
since October 2026
6in the last 12 months
over the period
over the period
Announcements visible on the feed
A detailed breakdown by type will follow as soon as the taxonomy allows.
Announcements
6Informations privilégiées / Autres communiquésMalakoff, le 5 novembre 2026, 18h00 CET - THERACLION (ISIN : FR0010120402 ; Ticker : ALTHE), société innovante développant Sonovein®, une plateforme de traitement non invasif des varices par ultrasons focalisés de haute intensité (HIFU), annonce aujourd’hui que la Food and Drug Administration…Inside Information / Other news releasesMalakoff, November 5, 2026, 6:00 pm CET - THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein®, a platform for the non-invasive treatment of varicose veins using High-Intensity Focused Ultrasound (HIFU), today announces that the U.S. Food and Drug…Informations privilégiées / Autres communiquésMalakoff, le 3 novembre 2026, à 18h (heure de Paris) - THERACLION (ISIN : FR0010120402 ; Mnémo : ALTHE), société innovante développant Sonovein®, une plateforme robotique de traitement non invasif des varices par ultrasons focalisés de haute intensité (HIFU), annonce avoir obtenu de l’autorité…Inside Information / Other news releasesMalakoff, 3 November 2026, at 6:00 pm CET – THERACLION (ISIN: FR0010120402; Ticker: ALTHE), an innovative company developing Sonovein®, a robotic platform for the non-invasive treatment of varicose veins using high-intensity focused ultrasound (HIFU), announces that it has obtained the Medical…Inside Information / Other news releasesInformations réglementées continues — 28 octobre 2026Informations privilégiées / Autres communiquésInformations réglementées continues — 28 octobre 2026